05/15/2024
4:18 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
4:21 PM | Molecular Templates (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2024
11:15 PM | Molecular Templates (Filer)
| Form EFFECT | |
04/29/2024
8:51 PM | Longitude Capital Partners III, LLC (Filed by)
Molecular Templates (Subject)
| Form SC 13D/A | |
04/25/2024
3:33 PM | Molecular Templates (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/12/2024
3:22 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
7:13 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/04/2024
3:57 PM | LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
8:56 PM | Molecular Templates (Subject)
SANTE HEALTH VENTURES I LP (Filed by)
| Form SC 13D/A | |
03/29/2024
3:06 PM | Molecular Templates (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2024
7:57 AM | Molecular Templates (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2024
7:45 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
7:22 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:08 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:39 PM | Molecular Templates (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
02/14/2024
3:45 PM | K2 HealthVentures Equity Trust LLC (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
02/14/2024
8:33 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
02/13/2024
10:00 AM | BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
01/25/2024
4:32 PM | Molecular Templates (Issuer)
Poma Eric E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
4:34 PM | Kim Jason S. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
4:49 PM | Molecular Templates (Issuer)
Voi Maurizio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:45 PM | LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:46 PM | Lanfear Jonathan (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:46 PM | Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:46 PM | Molecular Templates (Issuer)
SELICK HAROLD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:45 PM | Gruia Gabriela (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:45 PM | HOFFMANN DAVE (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
3:12 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
4:08 PM | Molecular Templates (Issuer)
Voi Maurizio (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/28/2023
4:01 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
4:08 PM | Molecular Templates (Filer)
| Form DEF 14A | |
09/12/2023
4:12 PM | Molecular Templates (Filer)
| Form DEFA14A | |
09/12/2023
4:15 PM | Molecular Templates (Filer)
| Form ARS | |
08/31/2023
5:22 PM | Gruia Gabriela (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2023
11:15 PM | Molecular Templates (Filer)
| Form EFFECT | |
08/10/2023
8:01 AM | Molecular Templates (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/10/2023
7:18 AM | Molecular Templates (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
7:09 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2023
4:09 PM | LYTTON LAURENCE W (Filed by)
Molecular Templates (Subject)
| Form SC 13G | |
07/19/2023
2:14 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
2:05 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Molecular Templates (Subject)
| Form SC 13G | |
Trump’s arrest is phase one (Ad) In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America.
It’s not just about blocking Trump’s re-election…  To get all the details, go here now. |
07/18/2023
10:56 AM | Molecular Templates (Filer)
| Form DEF 14A | |
07/13/2023
11:48 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:31 PM | Molecular Templates (Filer)
| Form PRE 14A | |
06/26/2023
4:27 PM | K2 HealthVentures Equity Trust LLC (Filed by)
Molecular Templates (Subject)
| Form SC 13G | |
06/20/2023
6:00 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
6:59 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
